Clinical Trial Update: Study of Neoadjuvant Docetaxel and Cyclophosphamide in Locally Advanced or Node Positive Primary Breast Cancer With Companion Pharmacokinetic and Pharmacogenomic Analyses [Phase 2]

View source ↗

Summary

Phase 2 neoadjuvant trial of docetaxel and cyclophosphamide with pharmacokinetic and pharmacogenomic analyses for locally advanced or node-positive breast cance…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• DOCETAXEL (DOCETAXEL)

Snippet

Sponsor: National Cancer Centre, Singapore | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED